Sinopharm from September 15 onwards, the Tianjin Property Rights Exchange Center Co., Ltd. Shijiazhuang Sinopharm listing to sell 80% stake in listed price 9.04 million yuan. Announcement shows that the subsidiary first and second largest shareholder is Sinopharm Tianjin and Hebei Pharmaceutical Co. Ltd., were holding 80% and 20% of its stake in Sinopharm for sale will clear the Shijiazhuang Co., Ltd. All ownership rights. Insiders said that in the fierce market competition, Sinopharm asset integration on the Fast Track.
Sinopharm Shijiazhuang Co.,China forehead thermometer Ltd are a small, but the operating range of diverse, covering chemical medicine, Chinese medicine, bio-pharmaceuticals, medical devices and other areas, regardless of chemical agents, antibiotic agents, or Chinese Herbal Medicine, chemical, antibiotics, bulk drugs, protein anabolic agents and peptide hormones, and thermometer, China electronic thermometer manufacturer magnetic devices, pregnancy diagnosis test strips, wheelchairs, warehousing services, are involved.
But the 2010 annual audit report, the company's profitability is low, current operating income of $ 168 million net profit of 10.89 million yuan. Assets Appraisal Co., LtdChina medical thermometer Shanghai East Asia made the latest asset valuation that the company is carrying a total of 174 million yuan of assets, liabilities of 165 million yuan, net assets of 9,717,300 yuan.digital blood pressure monitor Sinopharm that intention of the transferee to be successful in the transferee within 10 days after the equity ratio of one-time payment by the transferee company owed the subject Sinopharm Sinopharm Tianjin Hebei Pharmaceutical Co., Ltd., and all debts total 73.6629 million yuan, of which less Sinopharm Tianjin Co., Ltd.digital thermometer manufacturer 61,151,400 yuan.
Sinopharm tide in the competition without losing muscle. Back in 2007, the controlling shareholder China National Pharmaceutical Group to 5.328 million yuan price to Sinopharm National Pharmacy Co., Ltd. held by the transfer of the Beijing National Pharmacy Chain Co., Ltd. 74% stake, in order to enhance National retail pharmacy to expand pharmaceutical markets; 2008 , by the National Pharmaceutical Group to promote the integration of assets, digital thermometer in turn Sinopharm held 52.16% stake in Shenzhen, Chinese medicine for sale; 2010, Sinopharm shot again, will Meiluoyaoye its commercial distribution attributable to its assets and business, to expand the network and sales. In a series of action behind the integration of existing assets Sinopharm the overall planning, but also Sinopharm focus on the pharmaceutical distribution business.
Since 2010, the layout of the country to step up Sinopharm pharmaceutical distribution market. Year in late January, Sinopharm Fujian Fuzhou Co., Ltd. and the setting up; May and July, Sinopharm Guizhou and Inner Mongolia Co., Ltd. has inaugurated another, both point to the pharmaceutical distribution and logistics of modern medicine. In September, China National Pharmaceutical Group announced Sinopharm as a platform to invest in modern medicine in Changsha logistics center. In addition, Sinopharm Chongqing Co., Ltd., Anhui National pharmacy have appeared in the same year. As of December 2010, Sinopharm drug distribution, distribution network covering 29 provinces, municipalities and autonomous regions of the 133 cities above the prefectural level, city level and above accounted for 40%.
Into 2011, with circulation of drugs, "second Five Year Plan" promulgated by the close, Sinopharm the layout of the pharmaceutical circulation more triumph. In January, the National Pharmaceutical Holdings Co., Ltd. Heilongjiang, Meizhou Company, Jinzhou company, Changzhou company, Nanjing Company, Wuxi Company, Taizhou more than 10 pharmaceutical companies, distribution companies have been established.